MPP is looking for two new Expert Advisory Group (EAG) Members
- Expert in working with communities and non-governmental sector
- Intellectual property licensing and law expert
1. Background information
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with eleven patent holders for thirteen HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a long-acting technology and an experimental oral antiviral treatment for COVID-19. In 2020, MPP’s mandate was temporarily expanded to include COVID-19 treatments. In 2021 it was expanded further to include the licensing of technology with an initial focus on COVID-19 vaccines and pandemic preparedness.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC). MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government and SDC.
2. Expert Advisory Group role
The Expert Advisory Group has a consultative function. Its role as per MPP’s Statues and By-Laws is to:
- Review and provide advice to the Governance Board and the MPP’s Executive Director, upon request, with regard to general strategy and key management decisions;
- Provide a written report containing EAG’s recommendations to the Governance Board on the specifics of each licence agreement, which report will be submitted to the Board and ultimately published in the MPP web page, should the proposed agreement proceed to execution.
More information on the role of EAG and its Terms of Reference are available here:
3. Required profile of skills and expertise
MPP is looking for:
- an individual with expertise in working in/with the non-governmental sector and with communities living with disease(s) within MPP’s mandate.
- an expert in intellectual property licensing and intellectual property law with focus on access to medicines in LMICs.
The ideal candidate will also have a good understanding of the public health issues in LMICs as well as of the MPP model to improve access to affordable and appropriate essential medicines in LMICs.
4. Additional information
EAG members serve in their personal capacity and on an unremunerated basis. EAG members have to abide by MPP general policies. More on MPP policies
5. Time commitment
EAG members serve a three-year term renewable once. EAG meetings are normally convened once a year in person (all expenses paid) and teleconferences are organised in between as required according to MPP’s needs.
6. Application process
To apply please send your CV and covering letter outlining your relevant experience, expertise and interest in joining our EAG to firstname.lastname@example.org with the subject “EAG candidate nomination” by 12 December 2021 at midnight CET. You may also suggest someone in writing to the same email address and using the same subject line.
A list of suitable candidates will be compiled by the MPP Management and reviewed by the Governance Board in the first instance. Interviews will take place before a Board decision can be made. MPP is committed to achieving 50/50 gender balance and geographical diversity on its EAG.